Skip over main navigation
  • Log in
  • Basket: (0 items)
Emerge Australia
  • Twitter
  • Facebook
  • Email
Donate Become a member
Menu
  • About us
    • What we do
    • Our team
    • Our Ambassador
    • Our impact
    • Annual reports
    • Position Statements
    • Contact us
  • ME/CFS information
    • ME/CFS Information
    • Long COVID
    • Post-Exertional Malaise
    • Management
    • For health professionals
    • For carers
    • Member stories
  • Research
    • ME/CFS biobank and registry
    • Research Digest
    • Health and Wellbeing Survey
  • How to get help
    • Patient Support and Information Services
    • Telehealth Nurse Service
    • Online Community
    • GP Education Program
    • Accessing financial support
      • About NDIS
      • About DSP
      • NDIS and DSP Application Resources
  • Get involved
    • Give monthly
    • Donate
    • Fundraisers
    • Bequest giving
    • Emerge Australia Membership
    • Volunteer with us
    • Patient Advisory Group
    • Campaigns and advocacy resources
    • ME/CFS Awareness Week
  • Forum
  • News
  • Admin
    • Log in
  • Basket: (0 items)
  • GP Education Program

GP Education Program

Emerge Australia has partnered with ThinkGP to produce a two-part, RACGP accredited online education series. These modules are based on best-practice clinical information to assist health professionals to accurately diagnose and support patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

The two, one-hour modules are each worth RACGP C2 2pts or ACRRM 1pt on completion. Registered health professionals can enrol to complete the modules for free here. 

Module 1: Busting the myths and redefining myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

ME/CFS is a complex, chronic, debilitating disease with systemic effects, which is estimated to affect up to 250,000 Australians. This module aims to educate GPs and others working in the primary care space about our evolving understanding of ME/CFS as an illness and looks at some of the myths surrounding diagnosis and treatment.

On completion of this education activity participants will be able to:

  • Be aware of the latest developments in our understanding of the pathophysiology and resulting management of ME/CFS
  • Understand the benefits for patients of timely diagnosis of ME/CFS
  • Accurately diagnose ME/CFS based on the latest guideline recommendations
  • Implement a coordinated treatment plan to effectively address ME/CFS in general practice
  • Access and utilise tools and resources for optimising outcomes in patients with ME/CFS

Module 2: Ensuring a patient-centred approach to care for people living with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Providing care for people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) requires a patient-centred approach with a focus on quality of life and incorporating the multidisciplinary team.

This second module on ME/CFS provides detail on making a differential diagnosis, the non-core symptoms of ME/CFS, management in specific populations and the development of a patient-centred treatment plan.

On completion of this education activity participants will be able to:

  • Evaluate and reconsider management of ME/CFS, based on the latest developments in our understanding of ME/CFS pathophysiology
  • Identify exclusionary conditions, mimics and false diagnoses, to aid in the accurate diagnosis of ME/CFS
  • Plan strategies for managing non-core symptoms of ME/CFS including gastrointestinal symptoms and neurological symptoms, and for managing specific populations with ME/CFS (i.e. the severely unwell, young patients and those undergoing surgery)
  • Formulate a patient-centred treatment plan that accommodates the patient with ME/CFS in general practice
    Coordinate a multidisciplinary team approach, as appropriate, to optimise outcomes in patients with ME/CFS

If you would like to learn more about the module's content, get in touch with our Patient Support and Information Services team by contacting us here. If you are a healthcare professional, you can follow these links to Module 1 and Module 2.  Members of the general public are discouraged from completing the training through ThinkGP as it impacts the accuracy of our module completion figures. 

Help us to inform GPs and other healthcare practitioners about the education modules 

You can share this information page with your GP and other healthcare practitioners to inform them about the modules and encourage them to complete them and build their knowledge of ME/CFS. 

About ThinkGP

ThinkGP is Australia’s leading online continuing professional development (CDP) platform for health professionals. Education programs provided on ThinkGP are accredited by the Royal Australian College of General Practitioners (RACGP) and the Australian College of Rural and Remote Medicine (ACRRM).

Visit ThinkGP here. 

Published: 26th May, 2021

Updated: 12th May, 2022

Author: Sarah Corderoy

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Our GPs need to know what to do: We have the plan, we need the funds

    Our GPs need to know what to do: We have the plan, we need the funds

    Emerge Australia has written a 5 years plan for GP Education about ME/CFS, Long COVID and post-viral diseases, accessible to all of Australia’s GPs.

  • What will it take for Australia to get new clinical guidelines for ME/CFS?

    What will it take for Australia to get new clinical guidelines for ME/CFS?

    $1,200,000 is required over 2 years for the development of national clinical guidelines for ME/CFS It is a matter of urgency for Australia to update its clinical guidelines for ME/CFS, to ensure Australian ME/CFS patients have access to the best possible care, based on current understanding of the condition and latest evidence.

  • Australians with ME/CFS need Optimal Care Pathways

    Australians with ME/CFS need Optimal Care Pathways

    $1,100,000 is required over 5 years for an Optimal Care Pathway for ME/CFS. Optimal Care Pathways (OCP) support integrated shared care across the entire health system. Such innovative approaches to the coordination of non-clinical service delivery have achieved improved outcomes for patients in other settings.

  • Changes to the Support and Services programs

    Changes to the Support and Services programs

    With the completion of our Patient Pathways telehealth pilot program on June 30, 2022 we will be making some changes to how the service works and the programs it delivers.

Most read

  • What is ME/CFS?

    What is ME/CFS?

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others.

  • Contact Us

    Contact Us

    Emerge Australia provides an information line where you can find out about the latest news and information about ME/CFS.

  • What we do

    What we do

    Who we are and what we do

  • Volunteer with us

    Volunteer with us

    Join our small, friendly and enthusiastic team as a volunteer

  • How is functional impairment assessed?

  • Coronavirus and ME - Simplified facts

    Coronavirus and ME - Simplified facts

    Many people with ME/CFS and other vulnerable communities in Australia are concerned about the impacts of the spreading coronavirus disease COVID-19. This is an easy-read resource with the latest information and advice.

  • Annual reports

    Annual reports for Emerge Australia

  • Symposium

    Replace this with your content

  • Patient Advisory Group

    Patient Advisory Group

    The Patient Advisory Group provides Emerge Australia with ongoing advice about the needs of the community, as well as invaluable input into projects

  • What is ME/CFS?

    What is ME/CFS?

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, digestive, immune and cardiac systems. ME is classified as a neurological disorder by the World Health Organization.

Sign up to our newsletter

* indicates required


Specific mailing lists

Helpful links

  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Privacy Policy

Connect with us

  • Twitter
  • Facebook
  • YouTube


Get in touch with us

Emerge Australia
Level 7, 276 Flinders Street
Melbourne VIC 3000
1800 865 321
03 9529 1344
Media enquiries: 0400 165 391
 

Emerge Australia is registered as a charity with the Australian Charities and Not-for-profits Commission (ACNC). We are authorised by the Australian Tax Office as a deductible gift recipient (DGR). 

ABN/DGR: 22 385 438 041

Donations of $2 or more are tax-deductible. 

Emerge Australia acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the land and pays respect to their Elders past and present.

© 2019 Emerge Australia. All rights reserved.